Your browser doesn't support javascript.
loading
Corrigendum to "Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial" [Eur J Cancer 199 (2024) 113531].
Di Giacomo, Anna Maria; Chiarion-Sileni, Vanna; Del Vecchio, Michele; Ferrucci, Pier Francesco; Guida, Michele; Quaglino, Pietro; Guidoboni, Massimo; Marchetti, Paolo; Simonetti, Elena; Santangelo, Federica; Amato, Giovanni; Covre, Alessia; Camerini, Roberto; Valente, Monica; Mandalà, Mario; Giannarelli, Diana; Calabrò, Luana; Maio, Michele.
Afiliación
  • Di Giacomo AM; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy. Electronic address: annamaria.digiacomo@unisi.it.
  • Chiarion-Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Del Vecchio M; Unit of Melanoma, Medical Oncology, Department of Medical Oncology and Hematology, Istituto Nazionale dei Tumori, Milan, Italy.
  • Ferrucci PF; Department of Oncology Gruppo Multimedica, Milan, Italy.
  • Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Quaglino P; Dermatology Clinic, Department of Medical Science, University of Turin, Italy.
  • Guidoboni M; University of Ferrara, Italy.
  • Marchetti P; IRCCS IDI-Istituto Dermopatico dell'Immacolata, 00167, Rome, Italy.
  • Simonetti E; University of Siena, Siena, Italy.
  • Santangelo F; University of Siena, Siena, Italy.
  • Amato G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.
  • Covre A; University of Siena, Siena, Italy.
  • Camerini R; NIBIT Foundation Onlus, Italy.
  • Valente M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.
  • Mandalà M; University of Perugia, Santa Maria della Misericordia, University Hospital of Perugia, Italy.
  • Giannarelli D; Statistics, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
  • Calabrò L; University of Ferrara, Italy.
  • Maio M; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy.
Eur J Cancer ; 202: 113981, 2024 May.
Article en En | MEDLINE | ID: mdl-38461074
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Eur J Cancer Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Eur J Cancer Año: 2024 Tipo del documento: Article